RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAU7CA3B177605D85A1

https://w3id.org/ripe/ripe-kg/author/RIPEAU7CA3B177605D85A1
SubjectPredicateObject
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang rdf:type node1
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang rdf:type rdfs:Resource
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang rdf:type owl:Thing
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang rdf:type prov:Person
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang rdf:type foaf:Person
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang owl:sameAs https://semopenalex.org/author/A5064382373
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang foaf:familyName Huang
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang foaf:givenName Rong
ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang foaf:name Rong Huang
ripekg:retraction-notice/22368Variations in different polycystic ovary syndrome phenotypes in a population of Chinese Han ripe:concerns ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang
ripekg:retraction-notice/25763Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1α ripe:concerns ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang
ripekg:retraction-notice/43802Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway ripe:concerns ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang
ripekg:retraction-notice/51579Feasibility on the Integrated Teaching Method of Machine Learning Algorithm inside and outside Physical Education Class ripe:concerns ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang
ripekg:retraction-notice/55658HMGB3 Targeted by miR-145-5p Impacts Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells ripe:concerns ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial dcterms:creator ripekg:author/RIPEAU7CA3B177605D85A1Rong Huang